Roivant director plans $699K Rule 144 stock sale

Roivant Sciences director Meghan Fitzgerald filed a Rule 144 notice covering 20,000 common shares from a planned stock option exercise.

Rhea-AI Filing Summary

Roivant Sciences Ltd. (ROIV) director Meghan Fitzgerald filed a notice of proposed sales under Rule 144. The filing covers 20,000 common shares to be sold through Morgan Stanley Smith Barney, arising from an exercise of stock options for cash on September 8, 2026, with an aggregate market value of $698,600. The disclosure also notes that during the prior three months, Rule 10b5-1 sales by Meghan Fitzgerald included 10,000 common shares on June 30, 2026 for $349,000.

Key Figures

Planned shares to be sold: 20,000 shares Aggregate market value of planned sale: $698,600 Recent 10b5-1 sale volume: 10,000 shares +1 more

4 metrics

Planned shares to be sold 20,000 shares Common stock covered by the Rule 144 notice for September 8, 2026

Aggregate market value of planned sale $698,600 Value associated with the 20,000 common shares to be sold

Recent 10b5-1 sale volume 10,000 shares Common shares sold on June 30, 2026 under a Rule 10b5-1 plan

Aggregate value of recent 10b5-1 sale $349,000 Value of 10,000 common shares sold on June 30, 2026

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for MEGHAN FITZGERALD"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | | | 20000"

FAQ

What does the Form 144 filing disclose for ROIV?

The filing discloses that director Meghan Fitzgerald plans to sell 20,000 shares of Roivant Sciences Ltd. common stock under Rule 144 following an exercise of stock options for cash on September 8, 2026.

How many ROIV shares are covered by Meghan Fitzgerald’s planned Rule 144 sale?

The notice covers 20,000 common shares of Roivant Sciences Ltd. to be sold, with a reported aggregate market value of $698,600 as of the filing details.

What is the source of the ROIV shares to be sold by Meghan Fitzgerald?

The shares are to be issued upon the exercise of stock options by Meghan Fitzgerald, with the transaction described as an exercise of stock options for cash on September 8, 2026 and then sold under Rule 144.

Which broker is involved in Meghan Fitzgerald’s planned ROIV share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza in New York, as the broker handling the planned sale of 20,000 Roivant Sciences Ltd. common shares.

Were there recent 10b5-1 sales of ROIV shares by Meghan Fitzgerald?

Yes. The document notes Rule 10b5-1 sales for Meghan Fitzgerald of 10,000 common shares of Roivant Sciences Ltd. on June 30, 2026 for an aggregate value of $349,000 in the prior three months.

On which market are the ROIV shares in this Form 144 listed?

The securities referenced in the notice are common shares of Roivant Sciences Ltd., with the trading market identified as NASDAQ for the 20,000-share position described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:27 PM Accepted by SEC EDGAR 09/08/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001349297
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROIVANT SCIENCES LTD
SEC File Number	001-40782
Address of Issuer	7th Floor 50 Broadway London UNITED KINGDOM SW1H 0DB
Phone	442074003347
Name of Person for Whose Account the Securities are To Be Sold	MEGHAN FITZGERALD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	698600.00	722323015	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2026	Exercise of Stock Options	Issuer			20000	09/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MEGHAN FITZGERALD 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/30/2026	10000	349000.00

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Meghan Fitzgerald
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)